Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseAri Robicsek, David C. Hooper, Darren Abbanat et al.|Nature Medicine|2005Cited by 1k
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Veronica Gambillara Fonck, Christoph Hatz et al.|The Lancet Infectious Diseases|2017Cited by 209